Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Study of real-world treatment, healthcare resource use and costs in indolent NHLs, including Waldenström macroglobulinemia, finds significant economic burden increases across LOTs, highlighting need for better treatments.”
Title: Real-World Treatment Patterns, Healthcare Resource Use, and Costs in Patients with Follicular Lymphoma, Waldenström Macroglobulinemia, and Marginal Zone Lymphoma: A Claims-Based Study in the USA
Authors: Mahek Garg, Ambika Satija, Yan Song, Benjamin Meade, James Signorovitch, Shravanthi Gandra
You can read the full article on Clinical Drug Investigation.
You can find other articles featuring Robert Orlowski on OncoDaily.
